NCT06043830View on ClinicalTrials.gov

Managing Opioid Related Sleep Apnea With Acetazolamide

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

July 1, 2025

Study Completion Date

September 1, 2025

Conditions
Sleep-Disordered BreathingObstructive Sleep ApneaCentral Sleep ApneaChronic PainOpioid Use
Interventions
DRUG

Acetazolamide

Acetazolamide 250 mg 2 capsules by mouth nightly

OTHER

Placebo

Sugar capsule manufactured to match encapsulated Acetazolamide 2 capsules by mouth nightly

Trial Locations (1)

92037

RECRUITING

University of California San Diego, San Diego

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Diego

OTHER